Targeting the Optimal Antibody Strategy for a Noninvasive Diagnosis of Phospholipase A2 Receptor-Associated Membranous Nephropathy: Is Serology Alone Sufficient?
作者信息
Bobart Shane A, Fervenza Fernando C
机构信息
Division of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida.
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
出版信息
Clin J Am Soc Nephrol. 2025 May 1;20(5):598-600. doi: 10.2215/CJN.0000000710. Epub 2025 Apr 4.
Abstract
摘要
相似文献
1
Targeting the Optimal Antibody Strategy for a Noninvasive Diagnosis of Phospholipase A2 Receptor-Associated Membranous Nephropathy: Is Serology Alone Sufficient?靶向磷脂酶A2受体相关膜性肾病无创诊断的最佳抗体策略：仅靠血清学检测是否足够？
Clin J Am Soc Nephrol. 2025 May 1;20(5):598-600. doi: 10.2215/CJN.0000000710. Epub 2025 Apr 4.
2
Noninvasive Diagnosis of PLA2R-Associated Membranous Nephropathy: A Validation Study.PLA2R 相关膜性肾病的无创诊断：一项验证性研究。
Clin J Am Soc Nephrol. 2021 Dec;16(12):1833-1839. doi: 10.2215/CJN.05480421. Epub 2021 Nov 15.
3
Mass Spectrometry With Data-Independent Acquisition for the Identification of Target Antigens in Membranous Nephropathy.用于鉴定膜性肾病中靶抗原的数据非依赖型采集质谱分析
Am J Kidney Dis. 2025 Mar 7. doi: 10.1053/j.ajkd.2025.01.014.
4
Diagnostic utility of serum and urine biomarkers in idiopathic membranous nephropathy: a systematic review and meta-analysis.血清和尿液生物标志物在特发性膜性肾病中的诊断效用：系统评价和荟萃分析。
Int Urol Nephrol. 2023 Oct;55(10):2517-2526. doi: 10.1007/s11255-023-03561-w. Epub 2023 Mar 24.
5
Phospholipase A2receptor-positive membranous nephropathy detected by laser microdissection and mass spectrometry in patients negative by immunofluorescence for phospholipase A2receptor on kidney biopsy.在肾活检时磷脂酶A2受体免疫荧光检测呈阴性的患者中，通过激光显微切割和质谱法检测到磷脂酶A2受体阳性的膜性肾病。
Kidney Int. 2025 Jun 6. doi: 10.1016/j.kint.2025.04.032.
6
Lupus-like membranous nephropathy during the postpartum period expressing glomerular antigens exostosin 1/exostosin 2 and phospholipase A2 receptor: a case report.产后期表达外显子素 1/外显子素 2 和磷脂酶 A2 受体的狼疮样膜性肾病：一例报告。
CEN Case Rep. 2024 Oct;13(5):318-325. doi: 10.1007/s13730-023-00848-w. Epub 2024 Jan 27.
7
Combined Serologic and Genetic Risk Score and Prognostication of Phospholipase A2 receptor-Associated Membranous Nephropathy.联合血清学和遗传学风险评分与磷脂酶 A2 受体相关膜性肾病的预后评估。
Clin J Am Soc Nephrol. 2024 May 1;19(5):573-582. doi: 10.2215/CJN.0000000000000422. Epub 2024 Feb 29.
8
The essential role of electron microscopy in the diagnosis of collagen type III glomerulopathy superimposed with membranous nephropathy or diabetic nephropathy.电子显微镜检查在诊断合并膜性肾病或糖尿病肾病的III型胶原肾小球病中的重要作用。
BMC Nephrol. 2025 Jul 8;26(1):364. doi: 10.1186/s12882-025-04315-9.
9
Long-term Exposure to Complementary and Alternative Medicine Leads to Neural Epidermal Growth Factor-like 1 Membranous Nephropathy.长期接触补充和替代医学导致神经表皮生长因子样1膜性肾病。
J Assoc Physicians India. 2025 May;73(5):81-82. doi: 10.59556/japi.73.0960.
10
Detection and clinical significance of glomerular M-type phospholipase A receptor in patients with idiopathic membranous nephropathy.特发性膜性肾病患者肾小球 M 型磷脂酶 A 受体的检测及临床意义。
Intern Med J. 2016 Nov;46(11):1318-1322. doi: 10.1111/imj.13233.
本文引用的文献
1
Noninvasive Diagnostic Strategies for Membranous Nephropathy in the Nephrotic Syndrome Study Network.肾病综合征研究网络中膜性肾病的非侵入性诊断策略
Clin J Am Soc Nephrol. 2025 May 1;20(5):697-705. doi: 10.2215/CJN.0000000671. Epub 2025 Feb 28.
2
Membranous nephropathy-diagnosis and identification of target antigens.膜性肾病——诊断和靶抗原鉴定。
Nephrol Dial Transplant. 2024 Mar 27;39(4):600-606. doi: 10.1093/ndt/gfad227.
3
False-positive anti-PLA2R ELISA testing in patients with diabetes mellitus.糖尿病患者抗磷脂酶A2受体酶联免疫吸附测定的假阳性检测
Kidney Int. 2023 Feb;103(2):425. doi: 10.1016/j.kint.2022.11.004.
4
Noninvasive Diagnosis of PLA2R-Associated Membranous Nephropathy: A Validation Study.PLA2R 相关膜性肾病的无创诊断：一项验证性研究。
Clin J Am Soc Nephrol. 2021 Dec;16(12):1833-1839. doi: 10.2215/CJN.05480421. Epub 2021 Nov 15.
5
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases.KDIGO 2021肾小球疾病管理临床实践指南。
Kidney Int. 2021 Oct;100(4S):S1-S276. doi: 10.1016/j.kint.2021.05.021.
6
Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies.使用磷脂酶 A2 受体抗体进行原发性膜性肾病的无创诊断。
Kidney Int. 2019 Feb;95(2):429-438. doi: 10.1016/j.kint.2018.10.021.
7
Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies.肾脏活检全玻片数字成像上的间质纤维化评分是蛋白尿性肾小球疾病结局的预测因子。
Nephrol Dial Transplant. 2018 Feb 1;33(2):310-318. doi: 10.1093/ndt/gfw443.
8
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach.采用多学科方法评估原发性肾小球疾病的肾病综合征研究网络（NEPTUNE）的设计。
Kidney Int. 2013 Apr;83(4):749-56. doi: 10.1038/ki.2012.428. Epub 2013 Jan 16.
9
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.M型磷脂酶A2受体作为特发性膜性肾病的靶抗原
N Engl J Med. 2009 Jul 2;361(1):11-21. doi: 10.1056/NEJMoa0810457.
Zotero 插件